Scholarlink

<p>Alzheimer’s Disease (AD), the most common neurodegenerative disease, is underdiagnosed and more prominent in underrepresented groups. We performed semi-supervised positive unlabeled learning (SSPUL) coupled with racial bias mitigation for equitable prediction of undiagnosed AD from diverse populations at UCLA Health using electronic health records. SSPUL achieved superior sensitivity (0.77–0.81) and area under the precision recall curve (AUCPR) (0.81–0.87) across non-Hispanic white, non-Hispanic African American, Hispanic Latino, and East Asian groups compared to supervised baseline models (sensitivity: 0.39–0.53; AUCPR: 0.3–0.7). SSPUL also exhibited superior fairness as evidenced by the lowest cumulative parity loss. We identified top shared and distinct features among labeled and unlabeled AD patients, including those that are neurological (e.g., memory loss) and non-neurological (e.g., decubitus ulcer). We validated our results using polygenic risk scores, which were higher in labeled and predicted positives than in predicted negatives among non-Hispanic white, Hispanic Latino, and East Asian groups (<i>p</i> &lt; 0.001).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fair positive unlabeled learning for predicting undiagnosed Alzheimer’s disease in diverse electronic health records

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月27日

查看全文
  • Thai Tran,
  • Mingzhou Fu,
  • Jessica Fung,
  • Sriram Sankararaman,
  • David A. Elashoff,
  • Keith Vossel,
  • Timothy S. Chang

摘要

Alzheimer’s Disease (AD), the most common neurodegenerative disease, is underdiagnosed and more prominent in underrepresented groups. We performed semi-supervised positive unlabeled learning (SSPUL) coupled with racial bias mitigation for equitable prediction of undiagnosed AD from diverse populations at UCLA Health using electronic health records. SSPUL achieved superior sensitivity (0.77–0.81) and area under the precision recall curve (AUCPR) (0.81–0.87) across non-Hispanic white, non-Hispanic African American, Hispanic Latino, and East Asian groups compared to supervised baseline models (sensitivity: 0.39–0.53; AUCPR: 0.3–0.7). SSPUL also exhibited superior fairness as evidenced by the lowest cumulative parity loss. We identified top shared and distinct features among labeled and unlabeled AD patients, including those that are neurological (e.g., memory loss) and non-neurological (e.g., decubitus ulcer). We validated our results using polygenic risk scores, which were higher in labeled and predicted positives than in predicted negatives among non-Hispanic white, Hispanic Latino, and East Asian groups (p < 0.001).